Dr. Nicholas T. Potter appointed to the Medical Advisory Board of Epigenomics

Posted on June 11 2012 by Jonathan Mulkey

Dr. Nicholas T Potter has been appointed to the Medical Advisory Board of Epigenomics AG, a molecular diagnostics company developing and commercializing tests for the screening and diagnosis of cancer.  Their lead product Epi…
Read more


MPLN Offers Valuable Tests to Fight Breast Cancer Every Month

Posted on November 28 2011 by Jonathan Mulkey

In 2011, an estimated 230,480 new cases of invasive breast cancer will be diagnosed among women in the United States, and an estimated 57,650 cases of in situ breast cancer will be detected. To educate the public about breast cancer and the best ways…
Read more

Quigley, Potter Co-Author Article Comparing Two HPV Assays

Posted on July 30 2011 by Jonathan Mulkey

Drs. Neil Quigley and Nicholas Potter co-authored a recent article comparing two assays' detection rate of the human papillomavirus (HPV) in women 30 years of age and older.

The objective of the study was to estimate high-risk (HR) HPV…
Read more

4 5 6 7 8 next →